Johnson & Johnson: A Hidden Gem? Discover Their Surprising 2024 Outlook
In the unpredictable arena of pharmaceuticals, Johnson & Johnson (NYSE:JNJ) emerges as a formidable player, particularly renowned for its consistent dividend payouts. Amid the challenging 2024 landscape marked by patent cliffs and investment shifts towards smaller, strategic acquisitions, JNJ remains resilient. Despite